Письмо Росздравнадзора № 04И-329/12 от 28.04.2012 О качестве лекарственных средств Этот текст описывает различные события и людей, включая MirHHcTepcrso 3Ap!BooxptHcxr|', HcoqlajrEHoro pr3ExTas poccrlcKoi oaaepauxfi, @EAEPAJIbHAq CJIDKBA IrO IIA.tI3Opy, Cy6rexru o6paqeur.rt, JreKapcTBeHHLrX CpeAcTB, co4aAJrbIIOro PA3BI{TI,I', Poc2panH.lg3oP, Vnparnenz_a Pocs4panna4sopa, no cy66eKTElM Poccrfi croi @egepaqr,ru, CnaBrFcKar nr.4, crp. l, Mockla" 109074, TereQou: (495) 698 4628;698 46 tl, Opraursaquu, ocyulecrBJrrroqr4e, 'r( 01, {0/"1 r* OaU -.1J.//2, sKClepTV3y KaaIecTBa JTeKapcTBeHHLIX cpeAcTB, HaJ\!, Me4r.rqrluc xrne opranl{3 allnr4, O xa.recrBe JlekaperrBenHbrx cpeAcrB, Oprarrr ynpaBJreHwr 3ApaBooxpaHeHr{eM cy6rexroa poccufi cxofi @e.uepaqur.r, @e4epanrnar cJryx6a rro HaA3opy n ctf epe 3ApaBooxpa'e'r{r r corlr4anbHoro pa3Br'rrH{ Ha ocHoBaHrru ru(popuaqr4u, [ocrynr.rBureft or focygapcrnenuofi c,ryN6rr, Yrpazurr tto JIeKapcrBeHHhrM cpeAcrBau, coo6[1aer o BbrrBJre'rar{ a I rraprale 2Ol2 r. Ha reppr.rropau Vxpauurr Ha3saHI4e flpoueno4ureJrb, crpaua JreKapcTBeHHOrO CpeiqcTBa Hego6porauecrBeuHoe T4IIU $anrcrESrqupoBaHHoe neKapcTBeHHOe Vponecan@, Karmrl .uJUr rry"rpr 25 210310 run Ta6rerxu.ur,q p ac cacEIBAEX,i (ylaKoBKr.r sqefirosue rourypnrre) Ns18 $anrcr.lQuqupoBaHHoe Yrpar.rna ((pnarou-raneJrbHt4rIBr TeMHoro crerna/ s KOHTpOJIT KaqecTBa JreKapcTBeHHOFO CpeACTBa He4o6porcavecmenuoeI{JIU Sa.nrczQnqupoBanuoe neKapcTBeHHOe lparrarranltlrr@ c 1071r; AHECTETI,IKOM IIEO, 20711 ra6nerxra anq paccacrrBaur,ur .f, .refi OAO <Baneura (Dapvaqenrura>r, poccux ne4o6porauecrBeHHoe Pacna,{aenaocrr (ynarorru roerre xonrypnue) Merporan@, <<IO H ur Oupr,.rui rroil xd Jraooparopuc (Or4eneHr-re lpr.rpMbr I He4o6poravectseHHoe <{x.E.Keur.rxaac oHA @apnaacuorr.rrrurc JIrt>>),LIutua llo4lraunocru, KolrtlqectserBoe oIIpeAeJreHAe,
https://www.pharmcontrol.ru/rzn.php?letter=8663